2nd Annual MarketsandMarkets Real-World Evidence and Market Access Conference

2nd Annual MarketsandMarkets Real-World Evidence and Market Access Conference is organized by MarketsandMarkets Conferences and will be held from Oct 14 - 15, 2024 at Germany.

Key Highlights:
• Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies.
• Ensuring the reliability, validity, and relevance of RWE in the context of market access.
• Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes.
• Strategies for pricing and reimbursement that align with evidence-based market access approaches.
• The impact of patient-reported outcomes on demonstrating product value and effectiveness.
• The role of health economics in demonstrating the economic value of healthcare interventions.

Why Attend?
• Learn about the recent trends and advancements in Real-World Evidence Generation
• Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
• Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers